Bayer announced today that data from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented at the Heart Failure Society of America (HFSA)’s Annual Scientific Meeting ...
There’s a good chance that you haven’t heard about a rare condition called chromhidrosis. In a nutshell, the person afflicted with the disease produces colored sweat, from yellow to green, even red ...
Background Postoperative cerebral infarction following coronary artery bypass grafting (CABG) for multivessel coronary artery ...
Ongoing research and sustained efforts are creating optimism for more effective therapies and the possibility of a cure.
The European Society of Cardiology has recently published guidelines regarding the management of pericarditis and myocarditis.
Cardiovascular disease is a silent killer and a worldwide threat. According to the World Health Organization, 17-18 million ...
September 29 is World Heart Day, which was established by the World Heart Federation (WHF) to raise awareness about heart ...
During sleep, the body completes a number of essential actions necessary to maintain optimal health and function. However, ...
Extracorporeal cardiopulmonary resuscitation, also known as venoarterial extracorporeal membrane oxygenation, may provide a ...
Cardiac rehabilitation is a crucial, underutilized service for heart attack survivors, offering structured exercise programs ...
Over the last three decades, the evidence on how to best treat the cognitive and non-cognitive symptoms of patients with ...
On 15 September 2025, Regeneron Pharmaceuticals conducted a study is researching an experimental drug called REGN5381 (called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback